This report focuses on the global Needle-free Injection Systems status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Needle-free Injection Systems development in United States, Europe and China.

Needle-free injection systems are used to administer liquid formulations, drugs, and vaccines into patients without piercing the skin with a conventional needle.

Growth in this market is mainly driven by growing prevalence of chronic disease, increasing incidence of communicable disease due to needle stick injuries, rising demand for biosimilars and vaccination, advantages of drug delivery technology, increasing demand for self-injection devices. On the other hand, high development cost of needle-free injection systems over the conventional needle injection may hinder the growth of this market during the forecast period.

The vaccine delivery application segment is projected to be the fastest-growing segment during forecast period in 2017.

North America is expected to dominate the market in 2017, with the U.S. accounting for a major share. However, Europe is expected to grow at the highest CAGR during the forecast period.Asia-Pacific offers lucrative opportunities for the market growth, due to its high population base and growth in awareness about the benefits of needle-free injections and their application in treatment of cancer, diabetes, and other infectious diseases.

In 2017, the global Needle-free Injection Systems market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2018-2025.